International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064




Downloads: 0 | Views: 12

Informative Article | Pharmacotherapeutics | India | Volume 11 Issue 6, June 2022


Will Dostarlimab Become the New Rectal Cancer Drug of Choice?

Motupalli Sankeerth Kumar [2] | Ponnaluri Lalitha [2] | Seelam Victor John Wilson


Abstract: Information on a recent clinical trial in the United States on a drug that has been shown to be nearly 100% effective against rectal cancer in the sample population.


Keywords: Dostarlimab, Rectal cancer, new drug of choice


Edition: Volume 11 Issue 6, June 2022,


Pages: 1369 - 1369


How to Download this Article?

Type Your Email Address below to Download the Article PDF


How to Cite this Article?

Motupalli Sankeerth Kumar, Ponnaluri Lalitha, Seelam Victor John Wilson, "Will Dostarlimab Become the New Rectal Cancer Drug of Choice?", International Journal of Science and Research (IJSR), Volume 11 Issue 6, June 2022, pp. 1369-1369, https://www.ijsr.net/get_abstract.php?paper_id=SR22617214828





Top